Wockhardt Q2 Results
- BSE: 532300
- NSE: WOCKPHARMA
- ISIN: INE049B01025
- Sector: Biotechnology & Drugs
BSE
1,375.65
-52.35 (-3.67%)
-52.35 (-3.67%)Volume20.72 K
Updated: Fri 24 Jan, 2025 | 15:52:50
NSE
1,376.05-54.05 (-3.78%)
-54.05 (-3.78%)Volume4.76 L
Updated: Fri 24 Jan, 2025 | 15:59:44
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹809.00 Cr.(7.44%)
- Operating Profit₹75.00 Cr.(341.18%)
- Profit After Tax₹-22.00 Cr.(-71.43%)
- Operating Margin9.27%(310.64%)
Note: Comparison is on YoY basis
Quarterly - Wockhardt Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 809.00 | 739.00 | 9.47% | 753.00 | 7.44% |
| Selling/ General/ Admin Expenses Total | 161.00 | 160.00 | 0.63% | 166.00 | -3.01% |
| Depreciation/ Amortization | 55.00 | 54.00 | 1.85% | 55.00 | 0.00% |
| Other Operating Expenses Total | 221.00 | 174.00 | 27.01% | 228.00 | -3.07% |
| Total Operating Expense | 734.00 | 701.00 | 4.71% | 736.00 | -0.27% |
| Operating Income | 75.00 | 38.00 | 97.37% | 17.00 | 341.18% |
| Net Income Before Taxes | -9.00 | -6.00 | 50.00% | -35.00 | -74.29% |
| Net Income | -22.00 | -14.00 | 57.14% | -77.00 | -71.43% |
| Diluted Normalized EPS | -1.47 | -0.95 | 54.74% | -5.37 | -72.63% |